Core Diagnostics Private Limited

M&A Advisory

Service

April 2025

Date

Healthcare

Sector

INR 2,468 MN

Deal Value

Core Diagnostics Private Limited

Nuvama Contribution:

  • Exclusive financial advisor to Core Diagnostics Private Limited (“CDPL”) and its shareholders on its stake sale to Metropolis Healthcare Limited (“MHL”)
  • Played a crucial role in highlighting the investment thesis which helped garner strong interest from potential investors
  • Hand-holding the client through the complex M&A/structuring process and provided guidance on deal contours
  • Negotiated valuation and commercial terms resulting in desired outcomes for all shareholders

Deal Details:

  • Acquisition of 100% stake in CDPL by MHL for an equity value of INR 2,468MN
  • 55% consideration to be paid in cash and 45% consideration through share swap
  • CDPL is one of India’s leading Specialized Diagnostics players focused on Oncology segment and strong presence across North and East India region
  • CDPL has established strong connect with the Oncologists and tie-ups with leading cancer hospitals
  • Transaction offers significant synergies to MHL and is expected to be EPS accretive from FY26